EXELON 9.5 mg/24 h, medicated transdermal patch 30 patches in individual sachets
Active ingredients: Rivastigmine
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch30 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EXELON 9,5 mg/24 h, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 30 sachet(s) papier polyester aluminium polyacrylonitrile de 1 dispositif(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Apr 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63093669CIP73819491CIP133400938194913Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIVASTIGMINE BASEdispositif | 18 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.